T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services
- Agency
- New Jersey State Opportunities
- NAICS
- 325412 - Pharmaceutical Preparation Manufacturing
- Deadline
- 2026-10-27T00:00:00.000Z
- Place of performance
- New Jersey, United States